Gabapentin
- Product NDC
- 50090-5331
- 11-digit product format
- 500905331
- Labeler code
- 50090
- Product ID
- 50090-5331_0829c6b1-9255-4d03-bdcf-c4d06fcaf7f1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gabapentin
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA207057
- Marketing category
- ANDA
- Marketing start
- 2019-05-01
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 800 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5331-0 | 50090533100 | 60 TABLET, COATED in 1 BOTTLE (50090-5331-0) | 2020-11-02 | 0000-00-00 | No | No | Current |
| 50090-5331-1 | 50090533101 | 90 TABLET, COATED in 1 BOTTLE (50090-5331-1) | 2020-11-02 | 0000-00-00 | No | No | Current |
| 50090-5331-2 | 50090533102 | 30 TABLET, COATED in 1 BOTTLE (50090-5331-2) | 2020-11-02 | 0000-00-00 | No | No | Current |